ESTA News
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates
Establishment Labs (ESTA) delivered earnings and revenue surprises of -29.63% and +8.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates
Establishment Labs (ESTA) delivered earnings and revenue surprises of -29.63% and +8.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Establishment Labs Reports Third Quarter 2026 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2026. Third Quarter Business...
Business Wire
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Establishment Labs to Announce Third Quarter 2026 Financial Results on October 29
Establishment LabsHoldings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2026, before the market opens on...
Business Wire
Establishment Labs Receives FDA Approval for Additional Sizes of Motiva Implants
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded range of Motiva SmoothSilk...
Business Wire
Establishment Labs Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of new clinical and scientific data supporting Breast Tissue Preservation and its...
Business Wire
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture PR Newswire NEW YORK, Sept. 1, 2026 NEW...
PR Newswire
Baron Discovery Fund's Strategic Trim of Establishment Labs Holdings Inc (ESTA) Locks Gains
Baron Discovery Fund's Strategic Trim of Establishment Labs Holdings Inc (ESTA) Locks Gains...
Yahoo! Finance: News
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Establishment Labs (ESTA) delivered earnings and revenue surprises of -14.71% and +3.53%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Establishment Labs Reports Second Quarter 2026 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2026. Second Quarter Highlights and...
Business Wire